That is necessary, since the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be reliable. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (black sea). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a development almost no one observed. But it's going to have extensive ramifications for curing disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown 1 biotech). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it drew back perhaps significantly before going greater - brownstone research stock. I've been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. However that's not the huge concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown biotech stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of excellent personal companies on the brink of striking the general public markets And I've been working on a brand-new method for you to invest even before these companies go public.
This chance has actually been building over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to reserve your spot free of charge.
Emma Walsh here, managing editor of the Journal. Regular Diary readers know that tech isn't our typical beat (diplomatic relations). And when it comes to tech investing, we leave it to the professionals. Thankfully, we have numerous such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we understand (genetic sequencer stock jeff brown). In fact, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big image and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These patterns are experiencing exponential development and developing extraordinary chances for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. what is the legacy report predicting. But regardless of what lots of readers may think, this is a trend that's simply getting going. Even though the COVID-19 pandemic interrupted supply chains in 2015, an excellent 250 million 5G-enabled devices were still sold.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (exponential growth). Losing 2 months of production and sales truly impacts how lots of 5G gadgets are offered in the calendar year. When you consider all of that, offering 250 million units is impressive. More notably, the delays caused by the pandemic developed a load of suppressed need. Which need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - exponential growth. And that's not my only 5G prediction When I've spoken about 5G in the past, I have actually described its three different stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services start to be offered (jeff brown 1 biotech company). That's when we begin to see applications operating on 5G networks. Think about things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Phase Three by this summer. This begins something of a virtuous cycle: Many individuals do not really appreciate the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open up a suite of extraordinary applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances moving forward will be massive. Stepping away from 5G, the next crucial innovation I predict in 2021 is CRISPR genetic editing. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a comparable concept but with our genetic code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For years, CRISPR was mostly a niche innovation that wasn't well comprehended. And throughout that time, there were truly just three business operating in this area. But things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating illness and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and providing extraordinary returns. This entire market is effectively a greenfield chance.
There's space for many business to exist in this space. jeff brown biotech pick. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more genetic modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software application can precisely forecast the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is essential since the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has been a trial-and-error process. Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however numerous drug therapies produced utilizing this technology. This was one of those breakthroughs that practically nobody noticed. However it's going to have profound ramifications for curing illness. And, naturally, there will be lots of financial investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps considerably prior to going higher. I've been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin - united states. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. second wave. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info is up to date as of February 2021, but we could not separately verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to choose winning technology stocks. He spent more than 25 years investigating technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an outstanding perspective on the market. He's always on the hunt for brand-new chances, and he shares a number of his best choices in the Near Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully anticipated a few of the biggest economic occasions of the past twenty years. Although he doesn't appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it best each time, however Jeff Brown's precise forecasts have actually made him legions of devoted followers. That states a lot about his ability. The Future Report is released by Brownstone Research, a prominent financial research study publisher. Brownstone Research study uses several research services with a wide array of specializations - exponential growth.
The business is likewise associated with Bonner & Partners, another well-respected research study publisher - exponential tech investor. On its site, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the very best investment research has actually not been available to specific investors. It has actually been generally reserved for financial investment banks, hedge funds, personal equity, and high-net-worth customers. united states. The mission of Brownstone Research study is to make that type of proprietary research study readily available to any financiers seeking to get an edge in the marketplaces. The objective is simple to deliver distinct and rewarding investment research found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise functions as the company's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After decades of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout many of America. If you know even a little bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. future report review. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown believes S.A.V. self-driving cars. could be "the greatest trend of the 2020s, and he's not alone. Examine out these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying 2 cutting-edge innovations: synthetic intelligence and electric cars and trucks. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing brief of the automobile market's Holy Grail. As you understand, electrical automobiles and self-driving car stocks have actually been huge this year, however the Wall Street machine has actually been huge on hype without much tangible result. In spite of an extreme boost in competition over the previous couple of years, Brown still thinks Musk has the very best possibility of putting all of it together.
tech could be the magic string that connects everything together. S.A.V. represents Shared Autonomous Automobile, and it could be the future of transportation. Essentially, this innovation would allow you to lease out your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the automobile and press a button on an app that informs the cars and truck to "join the fleet." Next thing you understand, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a hefty chunk of the revenues. It sounds ridiculous, but it might be closed than you believe.